Neurocrine Bioscience buy Royal Bank of Canada
Start price
12.02.26
/
50%
€105.60
Target price
12.02.27
€149.00
Performance (%)
6.01%
Price
09.03.26
€111.95
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 6.01%. This prediction currently runs until 12.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -1.104% |
| iShares Core DAX® | -3.520% |
| iShares Nasdaq 100 | 0.261% |
| iShares Nikkei 225® | -4.953% |
| iShares S&P 500 | -0.823% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Royal Bank Of Canada from $180.00 to $177.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€137.35
08.12.25
08.12.25
€154.48
08.12.26
08.12.26
-18.49%
09.03.26
09.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€137.36
29.10.26
29.10.26
-5.01%
09.03.26
09.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.05
05.09.25
05.09.25
€127.74
05.09.26
05.09.26
-9.02%
09.03.26
09.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
-0.44%
09.03.26
09.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
2.85%
09.03.26
09.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
5.71%
09.03.26
09.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
34.26%
09.03.26
09.03.26

